Ibuprofen suppresses depressive like behavior induced by BCG inoculation in mice: Role of nitric oxide and prostaglandin

Pharmacology Biochemistry and Behavior

Volumn 125, Issue , 2014, Pages 29-39

  Saleh, Lobna A ^a   Hamza, May ^a   El Gayar, Nesreen H ^a   Abd El Samad, Abeer A ^b   Nasr, Essam A ^c   Masoud, Somaia I ^a  

^a African Union Organization St Abbassia   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c Agricultural Research Center   (Egypt)

Author keywords

Bacillus Calmette Guerin; Depression; Ibuprofen; Nitric oxide

Indexed keywords

CYCLOOXYGENASE 1; FLUOXETINE; IBUPROFEN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN; PROSTAGLANDIN E2; ARGININE; DRINKING WATER; INDUCIBLE NITRIC OXIDE SYNTHASE; BCG VACCINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; FORCED SWIM TEST; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMOBILITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCOMOTION; MALE; MOUSE; MYCOBACTERIUM BOVIS BCG; NONHUMAN; PRIORITY JOURNAL; TAIL SUSPENSION TEST; ANIMAL TISSUE; BRAIN LEVEL; COLONY FORMING UNIT; DRUG EFFECT; ENZYME INHIBITION; ENZYME SYNTHESIS; HIPPOCAMPUS; INOCULATION; TISSUE LEVEL; ANIMAL; BRAIN CHEMISTRY; CHEMISTRY; DRUG EFFECTS; MOTOR ACTIVITY; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BCG VACCINE; BRAIN CHEMISTRY; DEPRESSION; DINOPROSTONE; FLUOXETINE; HIPPOCAMPUS; IBUPROFEN; MALE; MICE; MOTOR ACTIVITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDINS;

EID: 84907258986     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.07.013     Document Type: Article

References (49)

1. S. Akhondzadeh, S. Jafari, F. Raisi, A.A. Nasehi, A. Ghoreishi, and B. Salehi et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial Depress Anxiety 26 7 2009 607 611
2. A.A. Bachmanov, D.R. Reed, G.K. Beauchamp, and M.G. Tordoff Food intake, water intake, and drinking spout side preference of 28 mouse strains Behav Genet 32 6 2002 435 443
3. J.B. Bancroft, and M. Gamble Theory and practice of histological techniques 6th ed. 2008 Churchill Livingstone Elsevier Philadelphia, PA
4. J.R. Calabrese, R.G. Skwerer, B. Barna, A.D. Gulledge, R. Valenzuela, and A. Butkus et al. Depression, immunocompetence, and prostaglandins of the E series Psychiatry Res 17 1 1986 41 47
5. L. Capuron, A. Ravaud, and R. Dantzer Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy J Clin Oncol 18 10 2000 2143 2151
6. S.H. Choi, S. Aid, and F. Bosetti The distinct roles of cyclooxygenase-1 and - 2 in neuroinflammation: implications for translational research Trends Pharmacol Sci 30 4 2009 174 181
7. F. Crespi The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): a feature of its antidepressant activity? Neurosci Lett 470 2 2010 95 99
8. M.A. Da-Rocha Jr., A.J. Puech, and M.H. Thiebot Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice J Psychopharmacol 11 3 1997 211 218
9. V.N. de Paiva, S.N. Lima, M.M. Fernandes, R. Soncini, C.A. Andrade, and A. Giusti-Paiva Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice Behav Brain Res 215 1 2010 146 151
10. S.C. Dulawa, K.A. Holick, B. Gundersen, and R. Hen Effects of chronic fluoxetine in animal models of anxiety and depression Neuropsychopharmacology 29 7 2004 1321 1330
11. M.S. Finkel, F. Laghrissi-Thode, B.G. Pollock, and J. Rong Paroxetine is a novel nitric oxide synthase inhibitor Psychopharmacol Bull 32 4 1996 653 658
12. A. Gadek-Michalska, and J. Bugajski Role of prostaglandins and nitric oxide in the lipopolysaccharide-induced ACTH and corticosterone response J Physiol Pharmacol 55 3 2004 663 675
13. M. Ghasemi, H. Sadeghipour, A. Mosleh, H.R. Sadeghipour, A.R. Mani, and A.R. Dehpour Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test Eur Neuropsychopharmacol 18 5 2008 323 332
14. M. Hamza, and R.A. Dionne Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition Curr Mol Pharmacol 2 1 2009 1 14
15. K.E. Hayes, J.A. Raucci Jr., N.M. Gades, and L.A. Toth An evaluation of analgesic regimens for abdominal surgery in mice Contemp Top Lab Anim Sci 39 6 2000 18 23
16. D. Johansson, A. Falk, M.M. Marcus, and T.H. Svensson Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat Prog Neuropsychopharmacol Biol Psychiatry 39 1 2012 143 148
17. M.P. Kaster, V.M. Gadotti, J.B. Calixto, A.R. Santos, and A.L. Rodrigues Depressive-like behavior induced by tumor necrosis factor-alpha in mice Neuropharmacology 62 1 2012 419 426
18. M. Krass, G. Wegener, E. Vasar, and V. Volke The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis Behav Brain Res 218 1 2011 57 63
19. M. Kubera, K. Curzytek, W. Duda, M. Leskiewicz, A. Basta-Kaim, and B. Budziszewska et al. A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4 months Brain Behav Immun 31 2013 96 104
20. M. Linnoila, A.R. Whorton, D.R. Rubinow, R.W. Cowdry, P.T. Ninan, and R.N. Waters CSF prostaglandin levels in depressed and schizophrenic patients Arch Gen Psychiatry 40 4 1983 405 406
21. A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, and C.J. Murray Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data Lancet 367 9524 2006 1747 1757
22. J. Mendlewicz, P. Kriwin, P. Oswald, D. Souery, S. Alboni, and N. Brunello Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study Int Clin Psychopharmacol 21 4 2006 227 231
23. A. Miclescu, and T. Gordh Nitric oxide and pain: 'something old, something new' Acta Anaesthesiol Scand 53 9 2009 1107 1120
24. S. Mikami, S. Kawashima, K. Kanazawa, K. Hirata, H. Hotta, and Y. Hayashi et al. Low-dose N omega-nitro-l-arginine methyl ester treatment improves survival rate and decreases myocardial injury in a murine model of viral myocarditis induced by coxsackievirus B3 Circ Res 81 4 1997 504 511
25. M. Moreau, J. Lestage, D. Verrier, C. Mormede, K.W. Kelley, and R. Dantzer et al. Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice J Infect Dis 192 3 2005 537 544
26. M. Moreau, C. Andre, J.C. O'Connor, S.A. Dumich, J.A. Woods, and K.W. Kelley et al. Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior Brain Behav Immun 22 7 2008 1087 1095
27. N. Müller, M.J. Schwarz, S. Dehning, A. Douhe, A. Cerovecki, and B. Goldstein-Muller et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine Mol Psychiatry 11 7 2006 680 684
28. H.S. Neto, V.U. Vomero, and M.J. Marques l-Arginine enhances muscle regeneration after experimental envenomation by B. jararacussu: a future for nitric oxide-based therapy? Toxicon 48 3 2006 353 357
29. J.C. O'Connor, M.A. Lawson, C. Andre, E.M. Briley, S.S. Szegedi, and J. Lestage et al. Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior J Immunol 182 5 2009 3202 3212
30. K. Ohishi, R. Ueno, S. Nishino, T. Sakai, and O. Hayaishi Increased level of salivary prostaglandins in patients with major depression Biol Psychiatry 23 4 1988 326 334
31. M.E. Page, M.J. Detke, A. Dalvi, L.G. Kirby, and I. Lucki Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test Psychopharmacology (Berl) 147 2 1999 162 167
32. H. Peters, W.A. Border, M. Ruckert, S. Kramer, H.H. Neumayer, and N.A. Noble l-Arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis Kidney Int 63 4 2003 1382 1392
33. B. Platt, J. Schulenberg, N. Klee, M. Nizami, and J.A. Clark A depressive phenotype induced by Bacille Calmette Guerin in 'susceptible' animals: sensitivity to antidepressants Psychopharmacology (Berl) 226 3 2013 501 513
34. R.D. Porsolt Animal models of depression: utility for transgenic research Rev Neurosci 11 1 2000 53 58
35. A. Reichenberg, J.M. Gorman, and D.T. Dieterich Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study AIDS 19 Suppl. 3 2005 S174 S178
36. D. Salvemini, T.P. Misko, J.L. Masferrer, K. Seibert, M.G. Currie, and P. Needleman Nitric oxide activates cyclooxygenase enzymes Proc Natl Acad Sci U S A 90 15 1993 7240 7244
37. D. Salvemini, K. Seibert, J.L. Masferrer, T.P. Misko, M.G. Currie, and P. Needleman Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation J Clin Invest 93 5 1994 1940 1947
38. O.J. Schiepers, M.C. Wichers, and M. Maes Cytokines and major depression Prog Neuropsychopharmacol Biol Psychiatry 29 2 2005 201 217
39. S. Sevgi, M. Ozek, and L. Eroglu l-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress Methods Find Exp Clin Pharmacol 28 2 2006 95 99
40. H. Sprott, R.E. Gay, B.A. Michel, and S. Gay Influence of ibuprofen-arginine on serum levels of nitric oxide metabolites in patients with chronic low back pain - a single-blind, placebo controlled pilot trial (ISRCTN18723747) J Rheumatol 33 12 2006 2515 2518
41. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl) 85 3 1985 367 370
42. T.A. Swierkosz, J.A. Mitchell, T.D. Warner, R.M. Botting, and J.R. Vane Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids Br J Pharmacol 114 7 1995 1335 1342
43. N. Takeichi, K. Suzuki, and H. Kobayashi Characterization of immunological depression in spontaneously hypertensive rats Eur J Immunol 11 6 1981 483 487
44. J.L. Teeling, C. Cunningham, T.A. Newman, and V.H. Perry The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: implications for a role of COX-1 Brain Behav Immun 24 3 2010 409 419
45. R.W. Vandivier, A. Eidsath, S.M. Banks, H.L. Preas II, S.B. Leighton, and P.J. Godin et al. Down-regulation of nitric oxide production by ibuprofen in human volunteers J Pharmacol Exp Ther 289 3 1999 1398 1403
46. J.R. Vane Purity and stability of synthetic peptides such as angiotensins and kinins Nature 230 5293 1971 382
47. Y. Wang, F. Yang, Y.F. Liu, F. Gao, and W. Jiang Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats Neurosci Lett 499 2 2011 74 79
48. J.L. Warner-Schmidt, K.E. Vanover, E.Y. Chen, J.J. Marshall, and P. Greengard Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans Proc Natl Acad Sci U S A 108 22 2011 9262 9267
49. I. Yaron, I. Shirazi, R. Judovich, D. Levartovsky, D. Caspi, and M. Yaron Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures Arthritis Rheum 42 12 1999 2561 2568